Ten cases of systemic lupus erythematosus related to hepatitis B vaccine

Lupus

Volumn 18, Issue 13, 2009, Pages 1192-1197

  Agmon Levin, N ^a   Zafrir, Y ^a   Paz, Z ^a   Shilton, T ^a   Zandman Goddard, G ^b,c   Shoenfeld, Yehuda ^a,c  

^a SHEBA MEDICAL CENTER   (Israel)

^b WOLFSON MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Autoimmunity; Hepatitis B vaccine; Hepatitis B virus; Lupus hepatitis; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; HEPATITIS B VACCINE; IMMUNOGLOBULIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL ARTICLE; DRUG INDUCED DISEASE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PHOTOSENSITIVITY; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANIMALS; FEMALE; HEPATITIS B VACCINES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 71049191842     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309345732     Document Type: Article

References (52)

1. Shoenfeld Y., Zandman-Goddard G., Stojanovich L., et al. The mosaic of autoimmunity: Hormonal and environmental factors involved in autoimmune diseases-2008. Israel Med Assoc J 2008; 10: 8-12.
2. Shoenfeld Y., Gilburd B., Abu-Shakra M., et al. The mosaic of autoimmunity: Genetic factors involved in autoimmune diseases - 2008. Israel Med Assoc J 2008; 10: 3-7.
3. Khamasthta MA, Hughes GRV, Brtolaccini ML Systemic lupus erythematosus. In: Shoenfeld Y, Cervera R, Gershwin ME (eds), Diagnostic Criteria in Autoimmune Disease (1st edn), Humana Press, Totova, New Jersey, USA, 2008: 3-8.
4. Al Arfaj AS, Khalil N. Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia. Lupus 2009; 18: 465-473.
5. Ippolito A., Petri M. An update on mortality in systemic lupus erythematosus. Clin Exp Rheum 2008; 26 (Suppl. 51): S72-S79.
6. Doria A., Briani C. Primary prevention of systemic lupus erythematosus. Nat Clin Pract Rheumatol 2008; 4: 576-577.
7. Zandman-Goddard G., Shoenfeld Y. SLE and infections. Clin Rev Allergy Immunol 2003; 25: 29-39.
8. Fineschi S. Can recombinant anti-hepatitis B vaccine be a cause of systemic lupus erythematosus? Lupus 2001; 10: 830.
9. Elkayam O., Ablin J., Caspi D., et al. Safety and efficacy of vaccination against streptococcus pneumonia in patients with rheumatic diseases. Autoimmun Rev 2007; 6: 312-314.
10. Abu-Shakra M., Press J., Buskila D., Sukenik S. Influenza vaccination of patients with systemic lupus erythematosus: Safety and immunogenecity issues. Autoimmun Rev 2007; 6: 543-546.
11. Aron Maor A., Shoenfeld Y. Vaccination and systemic lupus erythematosus: the bidirectional dilemmas. Lupus 2001; 10: 237-240.
12. Agmon-Levin N., Paz Z., Shoenfeld Y. Vaccination and autoimmunity. Nat Rev Rheumatol 2009; in press.
13. Tudela P., Martí S., Bonal J. Systemic lupus erythematosus and vaccination against hepatitis B. Nephron 1992; 62: 236.
14. Guiserix J. Systemic lupus erythematosus following hepatitis B vaccine. Nephron 1996; 74: 441.
15. Older SA, Battafarano DF, Enzenauer RJ, Krieg AM Can immunization precipitate connective tissue disease? Report of five cases of systemic lupus erythematosus and review of the literature. Semin Arthritis Rheum 1999; 29: 131-139.
16. Kuruma KA, Borba EF, Lopes MH, et al. Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus. Lupus 2007; 16: 0-4.
17. Cooper GS, Dooley MA, Treadwell EL, et al. Risk factors for development of systemic lupus erythematosus: Allergies, infections, and family history. Clin Epidemiol 2002; 55: 982-989.
18. Mercado U. Why have rheumatologists been reluctant to vaccinate patients with systemic lupus erythematosus? Rheumatology 2006; 33: 1469-1471.
19. Hanslik T., Vaillant JN, Audrain L., et al. Systemic lupus erythematosus and risk of hepatitis B vaccination: From the level of evidence to prescription. Rev Med Intern 2000; 21: 785-790.
20. Hochberg MC Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
21. Shepard CW, Simard EP, Finelli L., et al. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006; 28: 112-125.
22. Surveillance for acute viral hepatitis, United States, 2006. Surveillance Summaries 21 March 2008, Vol. 57, No. SS-2. MMWR, http://www.cdc.gov/mmwr.
23. Hepatitis B., http://www.who.int/mediacentre/factsheets/fs204/en/
24. Maillefert JF, Sibilia J., Toussirot E., et al. Rheumatic disorders developed after hepatitis B vaccination. Rheumatology 1999; 38: 978-983.
25. Geier DA, Geier MA A case-control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity 2005; 38: 295-301.
26. Geier MR, Geier DA A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: Analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review. Clin Exp Rheum 2004; 22: 749-755.
27. Maya R., Gershwin E., Shoenfeld Y. Hepatitis B virus (HBV) and autoimmune disease. Clinic Rev Allerg Immunol 2008; 34: 85-102.
28. Santoro D., Stella M., Montalto G., Castellin S. Lupus nephritis after Hepatitis B vaccination: An uncommon complication. Clin Nephrol 2007; 67: 61-63.
29. Hocine CP, Farrington E., Touze E., et al. Hepatitis B vaccination and first central nervous system demyelinating events: Reanalysis of a case-control study using the self-controlled case series method. Vaccination 2007; 25: 5938-5943.
30. Mikaeloff Y., Caridade G., Suissa S., Tardieu M. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology 2009; 72: 10.
31. Choffray A., Pinquier L., Bachelez H. Exacerbation of lupus panniculitis following anti-hepatitis B vaccination. Dermatology 2007; 215: 152-154.
32. Carvalho JF, Pereira RMR, Shoenfeld Y. Systemic polyarthritis nodosa following hepatitis B vaccination. Eur J Int Med 2008; 19: 575-578.
33. Geier DA, Geier MR A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administrated from 1994-2000 in the United States. Neuro Endocrinol Lett 2006; 5: 27.
34. Toplak N., Kveder T., Trampuš- Bakija A., et al. Autoimmune response following annual influenza vaccination in 92 apparently healthy adults. Autoimmun Rev 2008; 8: 134-138.
35. Classen JB, Classen DC Clustering of cases of insulin dependent diabetes (IDDM) occurring three years after hemophilus influenza B (HiB) immunization support causal relationship between immunization and IDDM. Autoimmunity 2002; 35: 247-253.
36. Kivity S., Agmon-Levin N., Blank M., Shoenfeld Y. Infections and autoimmunity - friends or foe? Trends Immunol 2009; 30: 409-414.
37. Huynh W., Cordato DJ, Kehdi E., et al. Post-vaccination encephalomyelitis: Literature review and illustrative case. J Clin Neurosci 2008; 15: 1315-1322.
38. Iñiguez C., Mauri JA, Larrodé P., et al. Acute transverse myelitis secondary to hepatitis B vaccination. Rev Neurol 2000; 31: 430-432.
39. Renard JL, Guillamo JS, Ramirez JM, et al. Acute transverse cervical myelitis following hepatitis B vaccination. Evolution of anti-HBs antibodies. Presse Med 1999; 28: 1290-1292.
40. Fonseca LF, Noce TR, Teixeira ML, et al. Early-onset acute transverse myelitis following hepatitis B vaccination and respiratory infection: case report. Arq Neuropsiquiatr 2003; 61: 265-268.
41. Friedrich F. Neurologic complications associated with oral poliovirus vaccine and genomic variability of the vaccine strains after multiplication in humans. Acta Virol 1998; 42: 187-194.
42. Sanna G., Marial ML, Bertolaccini MJ, et al. Neuropsychiatric manifestations in systemic lupus erythematosus: Prevalence and association with antiphospholipid antibodies. J Rheumatol 2003; 30: 985-992.
43. Matsukawa Y. Neuropsychiatric lupus (CNS lupus and PNS lupus). Nippon Rinsho 2009; 67: 531-535.
44. Sanna G., Bertolaccini ML, Khamashta MA Neuropsychiatric involvement in systemic lupus erythematosus: Current therapeutic approach. Curr Pharm Des 2008; 14: 1261-1269.
45. Rodriguez VE, Costas P. Systemic lupus erythematosus presenting as acute iceric hepatitis: A case report. Bol Asoc Med P R 2008; 100: 54-57.
46. Arnett FC, Reichlin M. Lupus hepatitis: An under-recognized disease feature associated with autoantibodies to ribosomal P. Am J Med 1995; 99: 465-472.
47. Price EJ, Venables PJ Drug-induced lupus. Drug Saf 1995; 12: 283-290.
48. Lasky T., Terracciano GJ, Magder L., et al. The Guillain Barre syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med 1998; 339: 1797-1802.
49. Ram M., Shoenfeld Y. Hepatitis B: Infection, vaccination and hepatitis B surface antigen. Autoimmunity. Israel Med Assoc J 2008; 10: 61-64.
50. Israeli E., Agmon-Levin N., Blank M., Shoenfeld Y. Adjuvants and autoimmunity. Lupus 2009.
51. Satoh M., Reeves WH Induction of lupus-associated autoantibodies in BALB/ c mice by intraperitoneal injection of pristane. J Exp Med 1994; 180: 2341-2346.
52. Kool M., Soullié T., van Nimwegen M., et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med 2008; 205: 869-882.